'Good news,' says doctor: Some Quebec COVID-19 patients to soon have access to monoclonal antibody treatment
Quebec is preparing to accept delivery of a small but potentially lifesaving shipment of a COVID-19 antibody treatment, which some doctors say will be a great added disease-fighting tool - if the province’s health authorities can organize the resources needed to drip it into patients’ arms.
The limited supply of the monoclonal antibody cocktail is being divvied up amongst the provinces by Canada’s Public Health Agency.
Quebec is to receive only “a few hundred doses,” according to a health ministry directive issued on Oct. 8.
"It’s a very important treatment for a special population of people who are vulnerable to severe complications," said Dr. Emily McDonald, a scientist in the infectious disease and immunity in global health program at the RI-MUHC.
These particular COVID-19 patients "may have done their best to protect themselves from seeking out the vaccine but weren't able to respond to it," said McDonald, who is also an internal medicine doctor.
Getting fully vaccinated remains the best and least costly avenue to prevent severe disease and hospitalization.
But for those who need them, the monoclonal antibodies, part of a class of medications, mimic the immune system’s ability to fight off the virus.
Quebec will be receiving a new combination of the antibodies: Casirivimab and Imdevimab.
According to INESSS, “if the drugs are used in a very targeted and timely way, they could help prevent hospitalizations."
WHO’S ELIGIBLE FOR TREATMENT?
The monoclonal antibodies are ideal for patients who are inadequately protected either because they have a medical condition that has compromised their immune systems, had organ transplants, chemotherapy treatment, or suffer from an autoimmune disease like rheumatoid arthritis, for example.
It is most effective when administered within seven days after a positive COVID-19 test.
Efficacy depends on several factors but in ideal circumstances, McDonald said "there are some studies that show that if you treat five people you might prevent one hospitalization, so pretty effective."
Late last month the World Health Organization backed the use of the antibodies in select, high-risk patients.
In light of the fourth wave and the current fragility of the health care network, Quebec's health ministry has asked health authorities to establish at least one site in a facility on their territory where the treatment can be administered.
It’s not a simple request, given that it involves bringing an outpatient who has COVID-19 into a hospital or clinic with all the risks and complications that entails.
And they’ll have to allocate the appropriate health care worker to the task, since the treatment itself is not a basic injection, but rather, involves an hour-long intravenous infusion.
WHAT TOOK SO LONG?
Monoclonal antibodies have been used extensively to treat COVID-19 in the United States for some time, so why haven’t Quebecers benefitted yet?
It seems that at least a couple of problems stood in the way- one biological and one logistical.
While a single monoclonal antibody, Bamlanivimab, was authorized by Health Canada in 2020, the treatment didn’t get a “positive enough recommendation” from scientists at Quebec’s institute for excellence in health (INESSS),” according to the health ministry and wasn’t rolled out extensively.
And then, whatever limited usefulness it had diminished over time as the virus continued to spread around the world, and changed.
“We found that that [with] the single monoclonal antibody...some of the variants were developing a resistance to it,” McDonald said.
There was also the previously mentioned issue around identifying a treatment site for outpatients and finding nurses who would be able to work there when needed.
But though there's limited data out the new combo-drug is performing better and will soon be accessible in the province - albeit in very limited supply.
“There remains this population of people who will never respond to the vaccine or respond poorly and it's I think it's really incredible that we have this treatment to offer them,” said McDonald.
CTVNews.ca Top Stories
Grandparents killed in wrong-way crash on Hwy. 401 identified
A 60-year-old man and a 55-year-old woman killed in a wrong-way crash on Highway 401 earlier this week have been identified by the Consulate General of India in Toronto.
Police arrest 3 Indian nationals in killing of B.C. Sikh activist Hardeep Singh Nijjar
Three people have been arrested and charged in the killing of B.C. Sikh activist Hardeep Singh Nijjar – as authorities continue investigating potential connections to the Indian government.
Suter scores late goal, clinches series for Canucks
Pius Suter scored with 1:39 left and the Vancouver Canucks advanced to the second round of the NHL playoffs with a 1-0 victory over the Nashville Predators on Friday night in Game 6.
TD worst-case scenario more likely after drug money laundering allegations: analyst
TD Bank Group could be hit with more severe penalties than previously expected, says a banking analyst after a report that the investigation it faces in the U.S. is tied to laundering illicit fentanyl profits.
Quebec man who threatened Trudeau, Legault online sentenced to 20 months in jail
A Quebec man who pleaded guilty to threatening Prime Minister Justin Trudeau and Premier François Legault has been sentenced to 20 months in jail.
Human remains found in rural Sask. possibly a decade old, RCMP say
RCMP say human remains found in a rural area in central Saskatchewan may have been there for a decade or more.
Britney Spears 'home and safe' after paramedics responded to an incident at the Chateau Marmont, source tells CNN
A source close to singer Britney Spears tells CNN that the pop star is 'home and safe' after she had a 'major fight' with her boyfriend on Wednesday night at the Chateau Marmont in West Hollywood.
Canadian doctor concerned new weight-loss drug Wegovy may be used inappropriately
As Wegovy becomes available to Canadians starting Monday, a medical expert is cautioning patients wanting to use the drug to lose weight that no medication is a ''magic bullet,' and the new medication is meant particularly for people who meet certain criteria related to obesity and weight.
Drew Carey is never quitting 'The Price Is Right'
Drew Carey took over as host of 'The Price Is Right' and hopes he’s there for life. 'I'm not going anywhere,' he told 'Entertainment Tonight' of the job he took over from longtime host Bob Barker in 2007.